Article PDF
References
Parren, P.W.H.I., Burton, D.R. & Sattenau, Q.J. HIV-1 antibody — debris or virion? Nature Medicine 3, 336 (1997).
Karpas, A. et al. Lytic infection by British AIDS virus and the development of rapid cell test for antiviral antibodies. Lancet ii 695–697 (1985).
Karpas, A. et al. Effect of passive immunization in patients with acquired immunodeficiency syndrome — related complex and acquired immunodeficiency syndrome Proc. Natl. Acad. Sci. USA 85, 9234–9237 (1988).
Karpas, A. et al. Polymerase chain reaction evidence for immunodeficiency virus-1 neutralization by passive immunization in patients with AIDS and AIDS-related complex. Proc. Natl. Acad. Sci. USA 87, 1195–1199 (1990).
Vittecoq, A. et al. Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. Inf. Diseases 265 364–368 (1992).
Levy, J. et al. Passive hyperimmune therapy in the treatment of AIDS: Results of a multicenter double-blind controlled trial. Blood, 265 2130–2135 (1992).
Vittecoq, D. et al. Passive immunotherapy in AIDS. A double-blind randomized study based on transfusions of plasma rich in anti human immunodeficiency virus 1 antibodies versus transfusions of seronegative plasma. Blood. 265 2130–2135 (1992).
Blick, G. et al. Passive immunotherapy in advanced HIV infection and therapeutic plasmaphoresis in asymptomatic HIV-positive individuals: A four-year clinical experience. Biother. (in the press).
Cao, Y. et al. Virologic and immunologic characterization of long term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332 201–208 (1995).
Pantaleo, G. et al. studies in subjects with long term non-progressive human immunodeficiency virus infection. N. Engl. J. Med. 332 209–216 (1995).
Jacobson, J.M. et al. Passive Immunotherapy in treatment of advanced human immunodeficiency virus infection - Reply. J. Infect. Dis. 170 743–744 (1994).
Lambert, J.S. et al. Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. J. Infect. Dis. 175 283–291 (1997).
Montefiori, D.C. et al. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long term non-progressors. J. Infect. Dis. 173 60–67 (1996).
Harrer, T. et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retroviruses. 12 585–592 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parren, P., Sattenau, Q. & Burton, D. Importance of anti-HIV-1 antibodies. Nat Med 3, 591 (1997). https://doi.org/10.1038/nm0697-591a
Issue Date:
DOI: https://doi.org/10.1038/nm0697-591a